Prophylactic HPV vaccines: a primary prevention approach for cervical cancer – what are the challenges?

ISSN： 1743-2871

Source： Papillomavirus Report, Vol.16, Iss.4, 2005-07, pp. : 262-264

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What's new with prophylactic HPV vaccines?

By Schiller John T.

Papillomavirus Report, Vol. 16, Iss. 2, 2005-03 ,pp. : 134-136

Maney Publishing

Access to resources Recommend Favorite

The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?

By Hennekens Charles H Bjorkman David J

Clinical Investigation, Vol. 3, Iss. 5, 2013-05 ,pp. : 447-449

Future Science

Access to resources Recommend Favorite

Does prevention of risk behaviour in primary care require a gender-specific approach? A cross-sectional study

By Vos Hedwig M M

Family Practice, Vol. 30, Iss. 2, 2013-04 ,pp. : 179-184

Oxford University Press

Access to resources Recommend Favorite

HPV and cervical cancer

Therapy, Vol. 5, Iss. 3, 2008-05 ,pp. : 273-277

Future Medicine

Access to resources Recommend Favorite

Prophylactic human papillomavirus vaccines to prevent cervical cancer: review of the Phase II and III trials

By Harper Diane M

Therapy, Vol. 5, Iss. 3, 2008-05 ,pp. : 313-324

Future Medicine

Access to resources Recommend Favorite